Skip to main navigation
Skip to search
Skip to main content
Research Nebraska Home
Help & FAQ
Home
Profiles
Research units
Facilities and Equipment
Research output
Projects
Activities
Prizes
Search by expertise, name or affiliation
Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management
Julie M. Vose
Oncology/Hematology
Oncology, Nebraska Medicine
James O Armitage Center for Hematological Malignancies Research
Fred & Pamela Buffett Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
76
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Mantle-Cell Lymphoma
100%
Survival
17%
Cyclin D1
16%
Stem Cell Transplantation
16%
idelalisib
12%
Bendamustine Hydrochloride
11%
Bone Marrow
11%
Lymph Nodes
10%
Genetic Translocation
9%
Follicular Lymphoma
9%
Bortezomib
9%
Cytarabine
8%
Allogeneic Cells
8%
B-Cell Chronic Lymphocytic Leukemia
8%
Combination Drug Therapy
7%
Leukocyte Count
7%
Non-Hodgkin's Lymphoma
7%
Milk
7%
Oxidoreductases
7%
Lymphoma
6%
Spleen
5%
Differential Diagnosis
5%
B-Lymphocytes
5%
Observation
5%
Immunohistochemistry
5%
Lymphocytes
5%
Therapeutics
5%
Clinical Trials
4%
Bone and Bones
4%
Recurrence
4%